Endothelin receptor antagonists: another potential alternative for cardiovascular diseases (2005)
Source: Current Drug Targets. Cardiovascular and Hematological Disorders. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
TOSTES, Rita C. A. e MUSCARÁ, Marcelo Nicolás. Endothelin receptor antagonists: another potential alternative for cardiovascular diseases. Current Drug Targets. Cardiovascular and Hematological Disorders, v. 5, n. 4, p. 287-301, 2005Tradução . . Acesso em: 18 jun. 2024.APA
Tostes, R. C. A., & Muscará, M. N. (2005). Endothelin receptor antagonists: another potential alternative for cardiovascular diseases. Current Drug Targets. Cardiovascular and Hematological Disorders, 5( 4), 287-301.NLM
Tostes RCA, Muscará MN. Endothelin receptor antagonists: another potential alternative for cardiovascular diseases. Current Drug Targets. Cardiovascular and Hematological Disorders. 2005 ; 5( 4): 287-301.[citado 2024 jun. 18 ]Vancouver
Tostes RCA, Muscará MN. Endothelin receptor antagonists: another potential alternative for cardiovascular diseases. Current Drug Targets. Cardiovascular and Hematological Disorders. 2005 ; 5( 4): 287-301.[citado 2024 jun. 18 ]